Literature DB >> 25173150

The pluripotency transcription factor network at work in reprogramming.

Hitoshi Niwa1.   

Abstract

Pluripotency-associated transcription factors possess a pivotal role to maintain pluripotency in pluripotent stem cells as well as to induce pluripotency in somatic cells. They direct specific pattern of gene expression from the genome by co-operating with the genetic and epigenetic mechanisms. Recent findings revealed that these mechanisms possess unique features in pluripotent stem cells, which is different from that in somatic cells either qualitatively and quantitatively. To reprogram somatic cells, pluripotency-associated transcription factors should modulate the co-operating machineries to establish the optimal environment for their function to maintain pluripotency-associated transcription factor network.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2014        PMID: 25173150     DOI: 10.1016/j.gde.2014.08.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  16 in total

1.  MED20 is essential for early embryogenesis and regulates NANOG expression.

Authors:  Wei Cui; Chelsea Marcho; Yongsheng Wang; Rinat Degani; Morgane Golan; Kimberly D Tremblay; Jaime A Rivera-Pérez; Jesse Mager
Journal:  Reproduction       Date:  2019-03       Impact factor: 3.906

Review 2.  A periodic table of cell types.

Authors:  Bo Xia; Itai Yanai
Journal:  Development       Date:  2019-06-27       Impact factor: 6.868

3.  The Histone Variant MacroH2A Blocks Cellular Reprogramming by Inhibiting Mesenchymal-to-Epithelial Transition.

Authors:  Maria Pliatska; Maria Kapasa; Antonis Kokkalis; Alexander Polyzos; Dimitris Thanos
Journal:  Mol Cell Biol       Date:  2018-04-30       Impact factor: 4.272

Review 4.  Glycans define the stemness of naïve and primed pluripotent stem cells.

Authors:  Shoko Nishihara
Journal:  Glycoconj J       Date:  2016-10-28       Impact factor: 2.916

Review 5.  Applications of aptamers in targeted imaging: state of the art.

Authors:  Casey A Dougherty; Weibo Cai; Hao Hong
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

Review 6.  Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses.

Authors:  Mark K Farrugia; Daniel B Vanderbilt; Mohamad A Salkeni; J Michael Ruppert
Journal:  Cancer Res       Date:  2016-03-10       Impact factor: 12.701

7.  Identification of a dynamic gene regulatory network required for pluripotency factor-induced reprogramming of mouse fibroblasts and hepatocytes.

Authors:  Maria Papathanasiou; Stefanos A Tsiftsoglou; Alexander P Polyzos; Deppie Papadopoulou; Dimitrios Valakos; Eleftheria Klagkou; Panagiota Karagianni; Maria Pliatska; Iannis Talianidis; Marios Agelopoulos; Dimitris Thanos
Journal:  EMBO J       Date:  2020-10-09       Impact factor: 11.598

Review 8.  Reprogramming of cell fate: epigenetic memory and the erasure of memories past.

Authors:  Buhe Nashun; Peter W S Hill; Petra Hajkova
Journal:  EMBO J       Date:  2015-03-27       Impact factor: 11.598

Review 9.  The Current State of Naïve Human Pluripotency.

Authors:  Benjamin T Dodsworth; Rowan Flynn; Sally A Cowley
Journal:  Stem Cells       Date:  2015-07-14       Impact factor: 6.277

10.  Impaired stem cell differentiation and somatic cell reprogramming in DIDO3 mutants with altered RNA processing and increased R-loop levels.

Authors:  Agnes Fütterer; Amaia Talavera-Gutiérrez; Tirso Pons; Jesús de Celis; Julio Gutiérrez; Verónica Domínguez Plaza; Carlos Martínez-A
Journal:  Cell Death Dis       Date:  2021-06-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.